$GEVA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SYNAGEVA BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SYNAGEVA BIOPHARMA CORP. Get notifications about new insider transactions in SYNAGEVA BIOPHARMA CORP for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 6.74 | 2,813 | 18,960 | 2,813 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 7.65 | 2,813 | 21,519 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 10.75 | 1,696 | 18,232 | 1,696 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 11.66 | 1,696 | 19,775 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 9.74 | 1,696 | 16,519 | 1,696 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 10.65 | 1,696 | 18,062 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 13.60 | 1,696 | 23,066 | 1,696 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 14.51 | 1,696 | 24,609 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 10.57 | 1,696 | 17,927 | 1,696 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 11.48 | 1,696 | 19,470 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 9.90 | 5,000 | 49,500 | 5,000 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 10.81 | 5,000 | 54,050 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 4.12 | 44,544 | 183,521 | 44,544 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 5.03 | 44,544 | 224,056 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 3.99 | 3,322 | 13,255 | 3,322 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 5.90 | 3,322 | 19,600 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 4.94 | 3,322 | 16,411 | 3,322 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 5.85 | 3,322 | 19,434 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 5.64 | 3,322 | 18,736 | 3,322 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 6.55 | 3,322 | 21,759 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 5.00 | 3,322 | 16,610 | 3,322 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 5.91 | 3,322 | 19,633 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 4.81 | 2,813 | 13,531 | 2,813 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 5.72 | 2,813 | 16,090 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 10.49 | 2,813 | 29,508 | 2,813 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 11.40 | 2,813 | 32,068 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 4.12 | 44,544 | 183,521 | 44,544 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 5.03 | 44,544 | 224,056 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 4.99 | 3,322 | 16,577 | 3,322 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 5.90 | 3,322 | 19,600 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 4.94 | 3,322 | 16,411 | 3,322 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 5.85 | 3,322 | 19,434 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 5.64 | 3,322 | 18,736 | 3,322 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 6.55 | 3,322 | 21,759 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 5.00 | 3,322 | 16,610 | 3,322 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 5.91 | 3,322 | 19,633 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 4.81 | 2,813 | 13,531 | 2,813 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 5.72 | 2,813 | 16,090 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 10.49 | 2,813 | 29,508 | 2,813 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 11.40 | 2,813 | 32,068 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 6.53 | 2,813 | 18,369 | 2,813 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 7.44 | 2,813 | 20,929 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 6.74 | 2,813 | 18,960 | 2,813 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 7.65 | 2,813 | 21,519 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 10.75 | 905 | 9,729 | 905 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 11.66 | 905 | 10,552 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 10.75 | 905 | 9,729 | 905 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 11.66 | 905 | 10,552 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 13.60 | 905 | 12,308 | 905 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 14.51 | 905 | 13,132 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 10.57 | 905 | 9,566 | 905 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 11.48 | 905 | 10,389 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 9.10 | 1,300 | 11,830 | 1,300 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 10.01 | 1,300 | 13,013 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 12.21 | 1,300 | 15,873 | 1,300 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 13.12 | 1,300 | 17,056 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 13.90 | 1,300 | 18,070 | 1,300 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 14.81 | 1,300 | 19,253 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 12.09 | 1,300 | 15,717 | 1,300 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 13.00 | 1,300 | 16,900 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 12.91 | 740 | 9,553 | 740 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 13.82 | 740 | 10,227 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 18.96 | 740 | 14,030 | 740 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 19.87 | 740 | 14,704 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 23.32 | 740 | 17,257 | 740 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 24.23 | 740 | 17,930 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 46.33 | 740 | 34,284 | 740 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 47.24 | 740 | 34,958 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 38.80 | 250 | 9,700 | 250 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 39.71 | 250 | 9,928 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 40.77 | 250 | 10,193 | 250 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 41.68 | 250 | 10,420 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 43.18 | 250 | 10,795 | 250 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 44.09 | 250 | 11,023 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 40.25 | 250 | 10,063 | 250 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 41.16 | 250 | 10,290 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 45.47 | 1,000 | 45,470 | 1,000 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 46.38 | 1,000 | 46,380 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Offshore GP, LLC | Director | Option Exercise | A | 4.12 | 20,000 | 82,400 | 20,000 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Offshore GP, LLC | Director | Option Exercise | D | 5.03 | 20,000 | 100,600 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Offshore GP, LLC | Director | Option Exercise | A | 4.48 | 40,000 | 179,200 | 40,000 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Offshore GP, LLC | Director | Option Exercise | D | 5.39 | 40,000 | 215,600 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | Director | Option Exercise | A | 4.12 | 20,000 | 82,400 | 20,000 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | Director | Option Exercise | D | 5.03 | 20,000 | 100,600 | 0 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | Director | Option Exercise | A | 4.48 | 40,000 | 179,200 | 40,000 | |
Jan 29 2009 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | Director | Option Exercise | D | 5.39 | 40,000 | 215,600 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | A | 4.12 | 13,750 | 56,650 | 13,750 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 5.03 | 13,750 | 69,163 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | A | 5.00 | 13,750 | 68,750 | 13,750 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 5.91 | 13,750 | 81,263 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | A | 4.79 | 20,000 | 95,800 | 20,000 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 5.70 | 20,000 | 114,000 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | MATTINGLY MARTIN A | Chief Executive Off ... | Option Exercise | A | 4.12 | 89,088 | 367,043 | 89,088 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | MATTINGLY MARTIN A | Chief Executive Off ... | Option Exercise | D | 5.03 | 89,088 | 448,113 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | MATTINGLY MARTIN A | Chief Executive Off ... | Option Exercise | A | 5.16 | 350,000 | 1,806,000 | 350,000 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | MATTINGLY MARTIN A | Chief Executive Off ... | Option Exercise | D | 6.07 | 350,000 | 2,124,500 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 4.12 | 15,000 | 61,800 | 15,000 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 5.03 | 15,000 | 75,450 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 5.00 | 15,000 | 75,000 | 15,000 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 5.91 | 15,000 | 88,650 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 4.79 | 20,000 | 95,800 | 20,000 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 5.70 | 20,000 | 114,000 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 4.12 | 15,000 | 61,800 | 15,000 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 5.03 | 15,000 | 75,450 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 5.00 | 15,000 | 75,000 | 15,000 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 5.91 | 15,000 | 88,650 | 0 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 4.79 | 20,000 | 95,800 | 20,000 | |
Jan 28 2009 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 5.70 | 20,000 | 114,000 | 0 | |
Dec 17 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Sell | S | 2.54 | 41,800 | 105,967 | 4,100 | 45.9 K to 4.1 K (-91.07 %) |
Dec 17 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Sell | S | 2.54 | 12,468 | 31,608 | 318,432 | 330.9 K to 318.4 K (-3.77 %) |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 5.90 | 3,322 | 19,600 | 3,322 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 7.04 | 3,322 | 23,387 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 5.85 | 3,322 | 19,434 | 3,322 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 6.99 | 3,322 | 23,221 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 6.55 | 3,322 | 21,759 | 3,322 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 7.69 | 3,322 | 25,546 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 5.91 | 3,322 | 19,633 | 3,322 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 7.05 | 3,322 | 23,420 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 5.72 | 2,813 | 16,090 | 2,813 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 6.86 | 2,813 | 19,297 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 11.40 | 2,813 | 32,068 | 2,813 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 12.54 | 2,813 | 35,275 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 7.44 | 2,813 | 20,929 | 2,813 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 8.58 | 2,813 | 24,136 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 7.65 | 2,813 | 21,519 | 2,813 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 8.79 | 2,813 | 24,726 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 11.66 | 905 | 10,552 | 905 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 12.80 | 905 | 11,584 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 11.66 | 905 | 10,552 | 905 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 12.80 | 905 | 11,584 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Grant | A | 0.00 | 15,000 | 0 | 16,955 | 2 K to 17 K (+767.26 %) |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 14.51 | 905 | 13,132 | 905 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 15.65 | 905 | 14,163 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 11.48 | 905 | 10,389 | 905 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 12.62 | 905 | 11,421 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 10.01 | 1,300 | 13,013 | 1,300 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 11.15 | 1,300 | 14,495 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 13.12 | 1,300 | 17,056 | 1,300 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 14.26 | 1,300 | 18,538 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 14.81 | 1,300 | 19,253 | 1,300 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 15.95 | 1,300 | 20,735 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 13.00 | 1,300 | 16,900 | 1,300 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 14.14 | 1,300 | 18,382 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 13.82 | 740 | 10,227 | 740 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 14.96 | 740 | 11,070 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 19.87 | 740 | 14,704 | 740 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 21.01 | 740 | 15,547 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 24.23 | 740 | 17,930 | 740 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 25.37 | 740 | 18,774 | 0 | |
Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 47.24 | 740 | 34,958 | 740 |